Fabrice Betoudji

Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis

Rokeya Tasneen, Fabrice Betoudji, Sandeep Tyagi et al. · Antimicrobial Agents and Chemotherapy · 2015 · 147 citations · Full text

A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections

Christopher P. Locher, Steven M. Jones, Brian L. Hanzelka et al. · Antimicrobial Agents and Chemotherapy · 2014 · 81 citations · Full text

Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis

Nicole C. Ammerman, Rosemary V. Swanson, Elaine M. Bautista et al. · Antimicrobial Agents and Chemotherapy · 2018 · 49 citations · Full text

Pulmonary Tuberculosis, Pharmacological Study, Medicine +14

Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model

Si‐Yang Li, Paul J. Converse, Fabrice Betoudji et al. · Antimicrobial Agents and Chemotherapy · 2023 · 43 citations · Full text

Mouse Tuberculosis Model, Mitochondrial Toxicity, Pulmonary Tuberculosis +15

Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis

Jean‐Philippe Lanoix, Fabrice Betoudji, Eric L. Nuermberger · Antimicrobial Agents and Chemotherapy · 2015 · 41 citations · Full text